Clinical Cancer Research, Vol 3, Issue 10 1781-1787, Copyright © 1997 by American Association for Cancer Research

ARTICLES

Cyclic adenosine-3',5'-monophosphate-mediated cytotoxicity in steroid sensitive and resistant myeloma

NL Krett, JL Zell, RG Halgren, S Pillay, AE Traynor and ST Rosen
Robert H. Lurie Cancer Center and Department of Medicine, Northwestern University, Chicago, Illinois 60611, USA. n-krett@nwu.edu

Multiple myeloma is a neoplastic proliferation of plasma cells. Glucocorticoids are among the most effective agents against multiple myeloma, acting through the glucocorticoid receptor to induce programmed cell death. However, some patients do not respond to glucocorticoids, and those that do respond eventually develop resistance to this therapy. Alternative strategies using drugs that mediate cytotoxicity through complementary pathways have theoretical appeal. Cyclic adenosine-3',5'-monophosphate (cAMP) derivatives are cytotoxic to a number of cell lines of lymphocytic origin. cAMP analogues activate protein kinase A, affecting cell growth and differentiation. The cascade of events initiated by cAMP derivatives and glucocorticoid, although distinct, may share some distal molecular targets. We have found that pharmacological concentrations of 8-chloro-cAMP, dibutyryl-cAMP, and 8-bromo-cAMP are cytotoxic to multiple myeloma cells, enhance glucocorticoid effects, and can kill glucocorticoid-resistant clones. cAMP analogues induce apoptosis as demonstrated by the fragmentation of myeloma DNA chromatin in a distinctive ladder pattern. In contrast to glucocorticoids, cAMP growth inhibition cannot be reversed by exogenous interleukin 6. cAMP derivatives have activity against multiple myeloma and are appropriate candidates for clinical trials.

This article has been cited by other articles:

				L. Zhang, A. C. Zambon, K. Vranizan, K. Pothula, B. R. Conklin, and P. A. Insel Gene Expression Signatures of cAMP/Protein Kinase A (PKA)-promoted, Mitochondrial-dependent Apoptosis: COMPARATIVE ANALYSIS OF WILD-TYPE AND cAMP-DEATHLESS S49 LYMPHOMA CELLS J. Biol. Chem., February 15, 2008; 283(7): 4304 - 4313. [Abstract] [Full Text] [PDF]

				K. Balakrishnan, C. M. Stellrecht, D. Genini, M. Ayres, W. G. Wierda, M. J. Keating, L. M. Leoni, and V. Gandhi Cell death of bioenergetically compromised and transcriptionally challenged CLL lymphocytes by chlorinated ATP Blood, June 1, 2005; 105(11): 4455 - 4462. [Abstract] [Full Text] [PDF]

				K. Ghias, C. Ma, V. Gandhi, L. C. Platanias, N. L. Krett, and S. T. Rosen 8-Amino-adenosine induces loss of phosphorylation of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2, and Akt kinase: Role in induction of apoptosis in multiple myeloma Mol. Cancer Ther., April 1, 2005; 4(4): 569 - 577. [Abstract] [Full Text] [PDF]

				N. L. Krett, K. M. Davies, M. Ayres, C. Ma, C. Nabhan, V. Gandhi, and S. T. Rosen 8-Amino-adenosine is a potential therapeutic agent for multiple myeloma Mol. Cancer Ther., November 1, 2004; 3(11): 1411 - 1420. [Abstract] [Full Text] [PDF]

				L. Zhang and P. A. Insel The Pro-apoptotic Protein Bim Is a Convergence Point for cAMP/Protein Kinase A- and Glucocorticoid-promoted Apoptosis of Lymphoid Cells J. Biol. Chem., May 14, 2004; 279(20): 20858 - 20865. [Abstract] [Full Text] [PDF]

				C. M. Stellrecht, C. O. Rodriguez Jr., M. Ayres, and V. Gandhi RNA-Directed Actions of 8-Chloro-Adenosine in Multiple Myeloma Cells Cancer Res., November 15, 2003; 63(22): 7968 - 7974. [Abstract] [Full Text] [PDF]

				C. Nabhan, D. Gajria, N. L. Krett, V. Gandhi, K. Ghias, and S. T. Rosen Caspase Activation Is Required for Gemcitabine Activity in Multiple Myeloma Cell Lines Mol. Cancer Ther., November 1, 2002; 1(13): 1221 - 1227. [Abstract] [Full Text] [PDF]

				R. Ogawa, M. B. Streiff, A. Bugayenko, and G. J. Kato Inhibition of PDE4 phosphodiesterase activity induces growth suppression, apoptosis, glucocorticoid sensitivity, p53, and p21WAF1/CIP1 proteins in human acute lymphoblastic leukemia cells Blood, May 1, 2002; 99(9): 3390 - 3397. [Abstract] [Full Text] [PDF]

				V. Gandhi, M. Ayres, R. G. Halgren, N. L. Krett, R. A. Newman, and S. T. Rosen 8-Chloro-cAMP and 8-Chloro-adenosine Act by the Same Mechanism in Multiple Myeloma Cells Cancer Res., July 1, 2001; 61(14): 5474 - 5479. [Abstract] [Full Text] [PDF]

				R. G. Halgren, A. E. Traynor, S. Pillay, J. L. Zell, K. F. Heller, N. L. Krett, and S. T. Rosen 8Cl-cAMP Cytotoxicity in Both Steroid Sensitive and Insensitive Multiple Myeloma Cell Lines Is Mediated by 8Cl-Adenosine Blood, October 15, 1998; 92(8): 2893 - 2898. [Abstract] [Full Text] [PDF]